These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 7586800

  • 21. Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway.
    Makowski GS, Ramsby ML.
    Inflammation; 1998 Jun; 22(3):287-305. PubMed ID: 9604716
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
    Afzal S, Lalani el-N, Foulkes WD, Boyce B, Tickle S, Cardillo MR, Baker T, Pignatelli M, Stamp GW.
    Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
    [Abstract] [Full Text] [Related]

  • 25. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
    Duivenvoorden WC, Hirte HW, Singh G.
    Invasion Metastasis; 1997 Feb; 17(6):312-22. PubMed ID: 9949290
    [Abstract] [Full Text] [Related]

  • 26. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis.
    Sato H, Seiki M.
    J Biochem; 1996 Feb; 119(2):209-15. PubMed ID: 8882706
    [Abstract] [Full Text] [Related]

  • 27. Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis.
    Lafuma C, El Nabout RA, Crechet F, Hovnanian A, Martin M.
    J Invest Dermatol; 1994 Jun; 102(6):945-50. PubMed ID: 8006459
    [Abstract] [Full Text] [Related]

  • 28. Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung.
    Kodate M, Kasai T, Hashimoto H, Yasumoto K, Iwata Y, Manabe H.
    Pathol Int; 1997 Jul; 47(7):461-9. PubMed ID: 9234385
    [Abstract] [Full Text] [Related]

  • 29. Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors.
    Gokaslan ZL, Chintala SK, York JE, Boyapati V, Jasti S, Sawaya R, Fuller G, Wildrick DM, Nicolson GL, Rao JS.
    Clin Exp Metastasis; 1998 Nov; 16(8):721-8. PubMed ID: 10211985
    [Abstract] [Full Text] [Related]

  • 30. Matrix metalloproteinase expression in human retinal microvascular cells.
    Grant MB, Caballero S, Tarnuzzer RW, Bass KE, Ljubimov AV, Spoerri PE, Galardy RE.
    Diabetes; 1998 Aug; 47(8):1311-7. PubMed ID: 9703333
    [Abstract] [Full Text] [Related]

  • 31. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
    Sugiura Y, Shimada H, Seeger RC, Laug WE, DeClerck YA.
    Cancer Res; 1998 May 15; 58(10):2209-16. PubMed ID: 9605768
    [Abstract] [Full Text] [Related]

  • 32. Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line.
    Kawashima A, Nakanishi I, Tsuchiya H, Roessner A, Obata K, Okada Y.
    Virchows Arch; 1994 May 15; 424(5):547-52. PubMed ID: 8032535
    [Abstract] [Full Text] [Related]

  • 33. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
    Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC.
    Stroke; 1998 May 15; 29(5):1020-30. PubMed ID: 9596253
    [Abstract] [Full Text] [Related]

  • 34. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma.
    Yoshizaki T, Sato H, Maruyama Y, Murono S, Furukawa M, Park CS, Seiki M.
    Cancer; 1997 Jan 01; 79(1):139-44. PubMed ID: 8988738
    [Abstract] [Full Text] [Related]

  • 35. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells.
    Abbas Abidi SM, Howard EW, Dmytryk JJ, Pento JT.
    Clin Exp Metastasis; 1997 Jul 01; 15(4):432-9. PubMed ID: 9219732
    [Abstract] [Full Text] [Related]

  • 36. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.
    Abe T, Mori T, Kohno K, Seiki M, Hayakawa T, Welgus HG, Hori S, Kuwano M.
    Clin Exp Metastasis; 1994 Jul 01; 12(4):296-304. PubMed ID: 8039304
    [Abstract] [Full Text] [Related]

  • 37. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N.
    Lab Invest; 1998 Jun 01; 78(6):687-98. PubMed ID: 9645759
    [Abstract] [Full Text] [Related]

  • 38. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments.
    Aimes RT, Quigley JP.
    J Biol Chem; 1995 Mar 17; 270(11):5872-6. PubMed ID: 7890717
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung.
    Nakagawa H, Yagihashi S.
    Jpn J Cancer Res; 1994 Sep 17; 85(9):934-8. PubMed ID: 7961122
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.